Press "Enter" to skip to content

Obesity and COVID; Diabetic Foot Test for AFib?

Obesity might be a bigger COVID-19 threat in men than women, with increased risks for severe pneumonia, intubation, and mortality seen among hospitalized patients. (European Journal of Clinical Microbiology & Infectious Diseases)

Could vitamin D help postmenopausal women stave off postoperative pain after a total knee replacement? (Menopause)

Bone Health Technologies announced it has finished securing a $2.5 million round of funding to continue assessing its OsteoBoost Vibration Belt for the prevention of osteoporosis and treatment of osteopenia.

Just one simple foot assessment can help diagnose atrial fibrillation in people with diabetes, according to a new study presented at the European Heart Rhythm Association meeting. “The yearly check-up includes palpating the arteries in the feet to examine whether there is healthy blood flow. During this examination we noticed that some patients had an irregular rhythm and decided to investigate its usefulness for diagnosing atrial fibrillation,” said lead study author Ilias Kanellos, MD, of the European University of Cyprus in Nicosia, in a statement.

The debate continues on the clinical benefit of levothyroxine in subclinical hypothyroidism. (The Pharmaceutical Journal)

Eli Lilly inked a deal with DexCom, Glooko, myDiabby Healthcare, and Roche to integrate technologies for streamlined diabetes management.

Aeterna Zentaris announced it is developing an investigational agent for the treatment of primary hypoparathyroidism in adults.

Medo, an artificial intelligence technology start-up company, announced its Medo-Thyroid ultrasound scanner received 510(k) FDA clearance.

  • Kristen Monaco is a staff writer, focusing on endocrinology, psychiatry, and dermatology news. Based out of the New York City office, she’s worked at the company for nearly five years.

Source: MedicalNewsToday.com